Rhythm Biosciences Limited (RHY) is involved in developing and commercialising Australian medical diagnostics technology for sale in domestic and international markets.
Rhythm Biosciences' ColoSTAT is the first proposed product-in-development, intended as a test for the accurate and early detection of colorectal cancer.